{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:27:45Z","timestamp":1795120065876,"version":"4.10.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":8883,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1093\/oxfordjournals.annonc.a059273","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T17:15:15Z","timestamp":1486142115000},"page":"631-632","source":"Crossref","is-referenced-by-count":14,"title":["Angioimmunoblastic T-cell lymphoma: New insights, but the clinical challenge remains"],"prefix":"10.1016","volume":"6","author":[{"given":"Elaine S.","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0005","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(74)90553-4","article-title":"Angio-immunoblastic lymphadenopathy with dysproteinemia","volume":"i","author":"Frizzera","year":"1974","journal-title":"Lancet"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197501022920101","article-title":"Immunoblastic lymphadenopathy: A hyperimmune entity resembling Hodgkin\u2019s disease","volume":"292","author":"Lukes","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0015","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1055\/s-0028-1106350","article-title":"Lymphogranulomatosis X: klinisches bild, therapie, und prognose","volume":"100","author":"Radaszkiewicz","year":"1975","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0020","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/1097-0142(197802)41:2<578::AID-CNCR2820410226>3.0.CO;2-8","article-title":"Malignant lymphoma arising in angioimmunoblastic lymphadenopathy","volume":"41","author":"Nathwani","year":"1978","journal-title":"Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V72.2.413.413","article-title":"Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive \u2018angioimmunoblastic lymphadenopathy with dysproteinemia-type\u2019 features","volume":"72","author":"Kaneko","year":"1988","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0030","first-page":"392","article-title":"Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"122","author":"Weiss","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0035","first-page":"549","article-title":"Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy","volume":"133","author":"Feller","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-4608(90)90233-Z","article-title":"Stepwise development of chromosomal abnormalities in angioimmunoblastic lymphadenopathy","volume":"50","author":"Schlegelberger","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0045","first-page":"1","article-title":"Angioimmunoblastic lymphadenopathy and related disorders: A retrospective look in search of definitions","volume":"3","author":"Frizzera","year":"1989","journal-title":"Leukemia"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00000478-199102000-00015","article-title":"Introduction to diagnostic problems in angioimmunoblastic lymphadenopathy","volume":"15","author":"Jaffe","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/1097-0142(19830715)52:2<318::AID-CNCR2820520221>3.0.CO;2-G","article-title":"Angioimmunoblastic lymphadenopathy: Long term clinical follow-up study","volume":"52","author":"Pangalis","year":"1983","journal-title":"Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.40.9.995","article-title":"Histopathology and immunohistochemistry of peripheral T-cell lymphomas: A proposal for their classification","volume":"40","author":"Suchi","year":"1987","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1093\/oxfordjournals.annonc.a059273_bb0065","first-page":"364","article-title":"Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM\/IMVP-16 regimen. A multicenter study","volume":"117","author":"Siegert","year":"1992","journal-title":"Kiel Lymphoma Study Group. Ann Intern Med"},{"issue":"7","key":"10.1093\/oxfordjournals.annonc.a059273_bb0070","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"issue":"1","key":"10.1093\/oxfordjournals.annonc.a059273_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V82.1.241.bloodjournal821241","article-title":"B-cell lymphoma after angioimmunoblastic lymphadenopathy: A case with oligoclonal gene rearrangements associated with Epstein-Barr virus","volume":"82","author":"Abruzzo","year":"1993","journal-title":"Blood"},{"issue":"7","key":"10.1093\/oxfordjournals.annonc.a059273_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","article-title":"Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: Prognostic impact of clinical observations and laboratory findings at presentation","volume":"6","author":"Siegert","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0085","first-page":"1023","article-title":"Validity of the Ann Arbor staging classification for the non-Hodgkin\u2019s lymphomas","volume":"61","author":"Rosenberg","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0090","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V83.5.1165.1165","article-title":"Prognostic factors in aggressive non-Hodgkin\u2019s lymphoma: Who has \u2018high risk\u2019 disease?","volume":"83","author":"Shipp","year":"1994","journal-title":"Blood"},{"issue":"14","key":"10.1093\/oxfordjournals.annonc.a059273_bb0095","first-page":"987","article-title":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project [see comments]","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1093\/oxfordjournals.annonc.a059273_bb0100","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: A proposal from the Internationa] Lymphoma Study Group [see comments]","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059273_bb0105","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: Summary and description of a Working Formulation for clinical usage","volume":"49","year":"1982","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419612962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419612962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/6\/7\/631\/373303\/6-7-631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:17:12Z","timestamp":1582247832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419612962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["S0923753419612962"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059273","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}